Cambridge scientists have successfully trialled an artificial pancreas for use by patients living with type 2 diabetes....

Cambridge scientists have successfully trialled an artificial pancreas for use by patients living with type 2 diabetes....

The increased alpha and beta cell sensitivity to glucose by DPP4 inhibitors modulate not only chronic hyperglycemia...

Diabetes patients frequently have CKD. About one in three persons with diabetes also has CKD. Kidney disease can be...

Clusters of cysts develop largely within your kidneys as a result of polycystic kidney disease (PKD), a genetic ailment...

Vildagliptin, a potent dipeptidyl peptidase IV inhibitor (DPP-4i), is usually administered twice daily to provide...

A recent study in Japan has shown that xanthangum-based fluid thickener can lower blood glucose levels after...

Catering to the pressing need to outline an evidence and experience-based comprehensive treatment yardstick, the...

New research published in Developmental Medicine & Child Neurology has revealed a link between maternal diabetes ...

A team of researchers from China, Taiwan and Australia aimed to determine whether metformin use was associated with a...

Among the gliptins, vildagliptin is the only therapy requiring twice-daily dosing and thus adversely impacts patient...

Intermittent fasting diets have become popular in recent years as an effective weight loss method. With intermittent...